摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-[tert-butyl(dimethyl)silyl]oxyethyl 4-methylbenzenesulfonate | 148400-72-0

中文名称
——
中文别名
——
英文名称
2-[tert-butyl(dimethyl)silyl]oxyethyl 4-methylbenzenesulfonate
英文别名
2-((tertbutyldimethylsilyl)oxy)ethyl 4-methylbenzenesulfonate;2-(tert-butyldimethylsiloxy)ethanol p-toluenesulfonate;2-(tert-butyldimethylsilyloxy)ethyl p-toluenesulfonate;1-(tert-Butyldimethylsilyloxy)-2-tosylethane;2-(tert-butyldimethylsilyloxy)ethyl tosylate;2-tert-butyldimethylsilyloxyethyl tosylate
2-[tert-butyl(dimethyl)silyl]oxyethyl 4-methylbenzenesulfonate化学式
CAS
148400-72-0
化学式
C15H26O4SSi
mdl
——
分子量
330.521
InChiKey
SURVAMFPFPDSHK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    387.2±25.0 °C(Predicted)
  • 密度:
    1.060±0.06 g/cm3(Predicted)
  • 溶解度:
    溶于氯仿

计算性质

  • 辛醇/水分配系数(LogP):
    3.72
  • 重原子数:
    21
  • 可旋转键数:
    7
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.6
  • 拓扑面积:
    61
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-[tert-butyl(dimethyl)silyl]oxyethyl 4-methylbenzenesulfonateIron(III) nitrate nonahydrate阻聚剂701 、 potassium chloride 、 氧气 作用下, 以 四氢呋喃 为溶剂, 以57 %的产率得到2-(P-甲苯磺酰氧基)乙酸
    参考文献:
    名称:
    铁催化硅醚有氧氧化生成羧酸
    摘要:
    已经开发出甲硅烷基醚直接有氧氧化成羧酸的方法。温和的反应条件导致广泛的官能团相容性。研究了不同类型的甲硅烷基并实现了选择性脱保护氧化。该反应可以在空气下进行。
    DOI:
    10.1039/d4cc01234h
  • 作为产物:
    描述:
    参考文献:
    名称:
    Novel derivatives of anaplastic lymphoma kinase inhibitors: Synthesis, radiolabeling, and preliminary biological studies of fluoroethyl analogues of crizotinib, alectinib, and ceritinib
    摘要:
    Anaplastic lymphoma kinase (ALK), an oncogenic receptor tyrosine kinase, is a therapeutic target in various cancers, including non-small cell lung cancer. Although several ALK inhibitors, including crizotinib, ceritinib, and alectinib, are approved for cancer treatment, their long-term benefit is often limited by the cancer's acquisition of resistance owing to secondary point mutations in ALK. Importantly, some ALK inhibitors cannot cross the blood-brain barrier (BBB) and thus have little or no efficacy against brain metastases. The introduction of a lipophilic moiety, such as a fluoroethyl group may improve the drug's BBB penetration. Herein, we report the synthesis of fluoroethyl analogues of crizotinib 1, alectinib 4, and ceritinib 9, and their radiolabeling with F-18 for pharmacokinetic studies. The fluoroethyl derivatives and their radioactive analogues were obtained in good yields with high purity and good molar activity. A cytotoxicity screen in ALK-expressing H2228 lung cancer cells showed that the analogues had up to nanomolar potency and the addition of the fluorinated moiety had minimal impact overall on the potency of the original drugs. Positron emission tomography in healthy mice showed that the analogues had enhanced BBB penetration, suggesting that they have therapeutic potential against central nervous system metastases. (C) 2019 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2019.111571
点击查看最新优质反应信息

文献信息

  • 2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS
    申请人:NOVARTIS AG
    公开号:US20210107889A1
    公开(公告)日:2021-04-15
    Provided herein are compounds according to Formula (I) or a pharmaceutically acceptable salt thereof, wherein R 1 , R 2 , R 3 , R 5 , and R 7 are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I) as well as the use of such compounds as M4 receptor agonists.
    本文提供了根据式(I)或其药学上可接受的盐的化合物,其中R1、R2、R3、R5和R7在此处被定义。本文还提供了包含式(I)化合物的药物组合物,以及将这些化合物用作M4受体激动剂的用途。
  • [EN] COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSÉS ET UTILISATIONS DE CES DERNIERS
    申请人:FOGHORN THERAPEUTICS
    公开号:WO2018213422A1
    公开(公告)日:2018-11-22
    The present invention features compounds useful in the treatment of BAF complex related disorders.
    本发明涉及用于治疗BAF复合物相关疾病的化合物。
  • Molecular design and chemical synthesis of potent enediynes. 1. Dynemicin model systems equipped with N-tethered triggering devices
    作者:K. C. Nicolaou、P. Maligres、T. Suzuki、S. V. Wendeborn、W. M. Dai、R. K. Chadha
    DOI:10.1021/ja00049a022
    日期:1992.11
    liberating the labile free amine intermediate.A number of tethering groups on the aromatic ring were also installed in these systems for future incorporation of other desirable moieties such as delivery systems and solubility enhancers.The chemical synthesis of the desired systems proceeded from the corresponding quinoline intermediates through acetylide additions to quinoline(intermolecular) and carbonyl(
    在本文中,描述了与动力霉素 A 结构相关并带有 N 系链触发装置的一系列烯二炔(12-19,图 I)的分子设计和化学合成。该设计设想连接在氮原子上的 [(芳基磺酰基)乙氧基]羰基作为 Bergman 环芳构化反应的触发装置,因为它能够在碱性条件下进行 β-消除,释放不稳定的游离胺中间体。芳环上的基团也安装在这些系统中,以便将来加入其他所需的部分,例如递送系统和溶解度增强剂。
  • One methylene unit to control super oil-repellency properties of conducting polymers
    作者:Thierry Darmanin、Frédéric Guittard
    DOI:10.1039/b822791h
    日期:——
    Keeping the length of the fluorinated tail constant, the modification of the alkylenedioxy bridge of 3,4-alkylenedioxypyrrole by one methylene unit, can control the superoleophobic properties of the electrodeposited conducting polymers.
    保持化尾的长度恒定,通过一个亚甲基单元对3,4-亚烷基二氧基吡咯的亚烷基二氧基桥的修饰可以控制电沉积导电聚合物的超疏油性能。
  • Facile Non-Racemizing Route for the N-Alkylation of Hindered Secondary Amines
    作者:Shabana S. Insaf、Donald T. Witiak
    DOI:10.1055/s-1999-3399
    日期:1999.3
    A simple, generally high yielding, method for the N-alkylation of sterically hindered secondary amines bearing α-substituents is described. Alkyl tosylates in the presence of 1,2,2,6,6-pentamethylpiperidine and toluene are essential for the production of the respective tertiary amines. Chiral amino acid derivatives studied do not racemize under the reaction conditions.
    本文介绍了一种简单、高产的方法,用于对含有δ-取代基的立体受阻仲胺进行 N-烷基化反应。在 1,2,2,6,6-五甲基哌啶甲苯存在下的烷基对甲苯磺酸盐对生产相应的叔胺至关重要。所研究的手性氨基酸生物在反应条件下不会发生外消旋。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫